Khaitan & Co Advised Neo Asset Management on Subscription of NCDs by Vizag Profiles Private Limited The leading law firm in India, Khaitan & Co acted as legal counsel to funds managed by Neo Asset Management Private Limited in relation to the subscription of unlisted, secured, unrated, redeemable non-convertible debentures aggregating INR 185 crore issued
... Continue Reading.Khaitan & Co Advised National Investment And Infrastructure Fund II on Block Trade Of Ather Energy Shares
Khaitan & Co Advised National Investment and Infrastructure Fund II on Block Trade of Ather Energy Shares The leading law firm in India, Khaitan & Co advised National Investment and Infrastructure Fund II (“NIIF”) in relation to the secondary sale of equity shares held by it in Ather Energy Limited, executed on the floor of
... Continue Reading.Shardul Amarchand Mangaldas Advised Main Capital Partners And BizzDesign on Acquisition Of Alfabet Business Assets In India
Shardul Amarchand Mangaldas Advised Main Capital Partners and BizzDesign on Acquisition of Alfabet Business Assets in India The leading law firm in India, Shardul Amarchand Mangaldas & Co. (SAM) advised Main Capital Partners and its portfolio company, BizzDesign, on Indian law aspects for the acquisition of business assets relating to the Alfabet Business in India
... Continue Reading.Khaitan & Co Advised ICICI Securities Limited On Issuance Of NCDs
Khaitan & Co Advised ICICI Securities Limited on Issuance of NCDs The leading law firm in India, Khaitan & Co acted as legal counsel to ICICI Securities Limited (“Issuer”) in connection with its issue of 50,000 fully paid, unsecured, rated, listed, redeemable, non-convertible debentures aggregating to INR 5,000 million (including an option to retain oversubscription
... Continue Reading.Shardul Amarchand Mangaldas Advised Tata Steel On Acquisition Of Stake In Thriveni Pellets Private Limited
Shardul Amarchand Mangaldas Advised Tata Steel on Acquisition of Stake in Thriveni Pellets Private Limited The leading law firm in India, Shardul Amarchand Mangaldas & Co. (SAM) advised Tata Steel Limited (“TSL”) on its acquisition of a 50.01% stake in Thriveni Pellets Private Limited (“TPPL”) from Thriveni Earthmovers Private Limited, for a consideration of up
... Continue Reading.S&A Law Offices Expands Western India Presence With Acquisition Of U&L Partners
S&A Law Offices Expands Western India Presence with Acquisition of U&L Partners The prominent full-service Indian law firm, S&A Law Offices, has acquired Ahmedabad-based boutique disputes firm U&L Partners, strengthening its dispute resolution capabilities and expanding its presence in western India. The founders of U&L Partners, Nilesh P Udernani and Gaurav K Lakhwani, will join
... Continue Reading.Part II- Disentangling Infringement and Disclosure in Novo: Should we continue to Celebrate Novartis?
Part II of the Novo v. Dr. Reddy judgement will shift the spotlight to prior claiming under sec. 64(1)(a). The inspiration to write this post came from a 2013 guest post by Darren Smyth, who was kind enough to have an hour long discussion with me on his post. The comments on that post, itself, are a trove of
... Continue Reading.Zaki Hashem, Attorneys At Law Advised Blue Aviation On Entry And Launch In Egypt
Zaki Hashem, Attorneys at Law Advised Blue Aviation on Entry and Launch in Egypt The prominent and historic Egyptian law firm, Zaki Hashem, Attorneys at Law, acted as lead legal adviser to Blue Aviation in supporting its entry into the Egyptian market and the successful launch of its aviation agency operations across all airports in
... Continue Reading.Not A Saathi After All: Why Sanchar Saathi Rings Alarm for Trade Secrets
The Sanchar Saathi application has largely been analysed as a privacy issue. However, as Anjali Tripathi argues in this entry for the SpicyIP–jhana Blogpost Writing Competition, it raises a more serious and underexplored concern—one that could directly threaten the protection of trade secrets and confidential business information in India’s smartphone-first economy. Anjali is a fifth-year
... Continue Reading.Data Exclusivity Debate Resurfaces Amidst US-FTA Talks, Evidence Still Missing
(Long post ahead!) A Central Drugs Standard Control Organization (CDSCO) notice has triggered fresh discussions on a data exclusivity regime for pharmaceutical products in India. The notice dated October 8 invites comments ‘to ensure a level playing field in new drug approval’. The notice reasons that applicants obtaining approval of a new drug for the
... Continue Reading.